What is the appropriate management and treatment for abdominal pain?

Management and Treatment of Abdominal Pain

The management of abdominal pain requires immediate assessment of hemodynamic stability, followed by structured diagnostic evaluation with imaging (CT with IV contrast for generalized pain, ultrasound for right upper quadrant pain), and early analgesia—which should not be withheld pending diagnosis—using IV paracetamol, dipyrone, or piritramide as first-line agents, with combinations of non-opioids and opioids for moderate-to-severe pain. 1, 2, 3

Initial Assessment and Diagnostic Approach

Hemodynamic Stabilization and Risk Stratification

• Ensure hemodynamic stability immediately upon presentation, as acute abdomen carries 2-12% mortality that increases with each hour of delayed treatment 4
• Assess for "red flag" symptoms requiring urgent intervention: unexplained weight loss, nocturnal pain, severe watery diarrhea, visible blood in stool, or signs of shock 5, 4
• The acute abdomen presents with sudden onset of maximally intense pain, often with guarding and impaired general well-being ranging to shock manifestations 4

Diagnostic Evaluation

• Obtain focused history examining pain location, onset, character, and associated symptoms (fever, vomiting, changes in bowel habits) 3
• Perform targeted physical examination including assessment for peritoneal signs, localized tenderness, and Carnett test (tenderness that stays the same or worsens with abdominal muscle tensing suggests abdominal wall pain rather than visceral pathology) 6
• Order initial laboratory tests: complete blood count, C-reactive protein, hepatobiliary markers, electrolytes, creatinine, glucose, urinalysis, lipase, and pregnancy testing in patients with female reproductive organs 3

Imaging Strategy

• For generalized/nonlocalized abdominal pain: CT with intravenous contrast is the preferred modality 1, 3
• For right upper quadrant pain: Ultrasound is the study of choice 3
• For lower abdominal pain: CT with IV contrast 3
• For pregnant patients: Ultrasound first; if inconclusive, use MRI rather than CT when available 3
• Point-of-care ultrasound can aid prompt diagnosis of cholelithiasis, urolithiasis, and appendicitis 3

Pain Management

Pre-Diagnostic Analgesia

Analgesia should be administered early and not withheld pending diagnosis, as pain therapy does not negatively influence diagnostic accuracy or treatment decisions. 2

First-Line Analgesic Agents

• For mild pain: IV paracetamol/acetaminophen (500-1000 mg, maximum 4-6 g/day) or NSAIDs with gastroprotection if prolonged use 1, 2
• For moderate-to-severe pain: Combinations of non-opioids and opioids, with IV piritramide as a preferred opioid option 2
• Adjust treatment based on repeated pain assessment using visual analogue scales (VAS), numerical rating scales (NRS), or verbal rating scales (VRS) 1

Specific Pain Management by Etiology

Cancer-Related Abdominal Pain

• Follow WHO analgesic ladder with stepwise escalation 1
• Mild pain (NRS 1-4): Acetaminophen or NSAID with gastroprotection 1
• Moderate pain (NRS 5-7): Combination products with weak opioids (codeine, tramadol) or low-dose strong opioids (morphine, oxycodone) 1
• Severe pain: Oral morphine as first choice; if parenteral administration needed, use one-third of oral dose 1
• Prescribe around-the-clock dosing with breakthrough doses (10% of total daily dose) for transient pain exacerbations 1
• Routinely prescribe laxatives for opioid-induced constipation prophylaxis 1

Functional Abdominal Pain (IBS-type)

• Dietary interventions: Soluble fiber supplementation (ispaghula 3-4 g/day) improves global symptoms and pain; avoid insoluble fiber like wheat bran 5
• Second-line dietary therapy: Low-FODMAP diet supervised by trained dietitian with gradual reintroduction 5
• Antispasmodics: Reduce global symptoms and abdominal pain; titrate carefully due to anticholinergic effects (dry mouth, visual disturbances, dizziness) 5
• Loperamide: For diarrhea control, individualized dosing 5
• Probiotics: Trial for up to 12 weeks; discontinue if no benefit 5
• Neuromodulators (second-line): Tricyclic antidepressants (amitriptyline 10 mg daily, titrated to 30-50 mg) for persistent symptoms 5

Abdominal Wall Pain

• Suspect when there is localized small tender spot with positive Carnett test and no visceral symptoms 6
• Treatment: Local injection with anesthetic and corticosteroid achieves 70-99% response rate for anterior cutaneous nerve entrapment syndrome 6
• For refractory cases requiring more than two injections, consider surgical neurectomy 6

Condition-Specific Management

Acute Appendicitis

• Administer antimicrobial therapy effective against facultative/aerobic gram-negative organisms and anaerobes to all patients with confirmed appendicitis 1
• Operative intervention (laparoscopic or open appendectomy) should be performed as soon as reasonably feasible 1
• For equivocal imaging, initiate antimicrobials with minimum 3-day course until symptoms resolve or definitive diagnosis made 1
• Well-circumscribed periappendiceal abscess can be managed with percutaneous drainage; appendectomy generally deferred 1

Complicated Intra-Abdominal Infection

• Urgent source control procedure required for perforated viscus or peritonitis 1
• Antimicrobial therapy targeting mixed aerobic/anaerobic flora 1
• Consider exploratory laparoscopy when diagnosis remains uncertain despite imaging 1

Microscopic Colitis (when confirmed by colonoscopy with biopsies)

• First-line: Budesonide 9 mg daily (66% relative risk reduction of clinical relapse over 6 months) 5
• Alternative agents: Mesalamine (moderate evidence), bismuth salicylate (low evidence), prednisolone/prednisone (very low evidence) 5
• Maintenance after relapse: Restart budesonide at 6 mg daily, taper to lowest effective dose 5

Critical Pitfalls to Avoid

• Do not withhold analgesia pending diagnosis—this outdated practice delays pain relief without improving diagnostic accuracy 2
• Avoid IgG antibody-based food elimination diets for symptom control in functional pain 5
• Do not prescribe gluten-free diets unless celiac disease is confirmed 5
• Avoid long-term opioids in functional abdominal pain; refer to multidisciplinary chronic pain team if narcotic bowel syndrome develops 1
• Do not perform repeated investigations in patients with secure IBS diagnosis and severe symptoms—the yield is low 1
• Avoid NSAIDs in patients at bleeding risk or with renal impairment; use caution with prolonged NSAID therapy 1

Follow-Up and Escalation

• Evaluate treatment response within 2-4 weeks of initiating dietary interventions; escalate to pharmacologic therapy if no improvement 5
• For severe or refractory symptoms, review diagnosis and consider targeted investigation to exclude organic pathology 1, 5
• Consider referral to multidisciplinary team for integrated management of severe/refractory cases 1
• Exclude other contributors: small intestinal bacterial overgrowth, bile-acid malabsorption, pancreatic insufficiency, inflammatory bowel disease 5